DS

Durairaja Subbarayalu

Director Director DIN 02430351
DIN 02430351 First appointment Dec 2008 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2008
Shareholding value Locked Premium profile

About Durairaja Subbarayalu

Durairaja Subbarayalu has 17 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

DIN 02430351
Primary Designation Director
First Appointment 03 Dec 2008
Oldest Company Age 17 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Axiogen Biotech Private Limited U24100PY2008PTC002242
Director 03 Dec 2008 2008 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Axiogen Biotech Private Limited
Premium access

Shareholding and investment profile for Durairaja Subbarayalu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Durairaja Subbarayalu

Durairaja Subbarayalu has 17 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

Durairaja Subbarayalu is associated with 0 companies as Director.

Durairaja Subbarayalu has expertise in Technology.

Durairaja Subbarayalu has 17 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available